Project: Speech and language phenotyping in Okur-Chung neurodevelopmental syndrome

Lead Investigator: Miya St. John, BSc, MAppLing, MSpPath, PhD | Murdoch Children’s Research Institute
Grant Details:
Project funded for 1 year starting in 2025 for a total of $33,705.05.
Aims of Grant:
Speech and language challenges have been reported in individuals with OCNDS. These include delayed communication milestones, atypical oral-motor skills, significantly delayed literacy development, and non-specific “impaired speech ability,” as well as autism and autistic features (see Chiu et al., 2017; Okur et al., 2016; Owen et al., 2018). However, the communication profile remains poorly characterized. No studies to date have examined speech and language systematically, nor used standardized or formal assessments to distinguish between speech and language diagnoses. Speech refers to the physical production of sounds, while language refers to understanding and using words and sentences; the distinction is often misunderstood but clinically important.
As a result, current understanding of OCNDS lacks a clear separation between motor-based speech disorders (e.g., speech apraxia, a condition in which the brain has difficulty coordinating the movements needed for speech) and cognitive-linguistic impairments (difficulties in the thinking processes involved in understanding and using language). This distinction is critical for patient care. Without accurate diagnoses, parents and clinicians remain unsure about which therapies to implement, or may use incorrect therapies, resulting in wasted time, resources, and money, without positive outcomes.
This project aims to characterize the speech and language abilities of individuals with CSNK2A1 variants, and in doing so will:
- Provide definitive diagnoses, prognoses, and a treatment planning guide for families and clinicians
- Investigate whether there are clinical differences corresponding to the CSNK2A1 variant location within the gene, known as genotype-phenotype correlation, to more specifically inform prognosis
- Use collected data to identify optimal speech and language outcome measures to be used in future clinical trials
